New continuous glucose monitoring sensors (small sensors that penetrate the skin to measure glucose levels in real time) are now hitting the wearables market for use among individuals without diabetes. Despite a lack of research showing that using these sensors improves health outcomes in individuals without diabetes, there is a growing interest among this population. […]
The study was done by researchers at BU Chobanian & Avedisian School of Medicine, BMC’s Center of Excellence in Sickle Cell Disease, and the BU Evans Center for Implementation and Improvement Sciences.
Budson has been awarded a two-year, $150,000 grant with collaborator Daniel Levy, PhD, at Reichman University, Herzliya, Israel, from the U.S. Israel Binational Science Foundation.
Patients also reported higher opioid use, slightly lower PT use.
More than 25 million people are impacted by chronic venous insufficiency (CVI) which includes varicose and spider veins. These can be treated with sclerotherapy.
Findings provide a new focus for the investigation of therapeutics.
Nation’s longest-running study of heart disease will be led by former American Heart Association president Donald M. Lloyd-Jones.
Women with severe endometriosis are 10 times more likely to get ovarian cancer, compared to women who do not have the disease.
Study findings also suggest that mental health symptoms in persons in early stages of AD could be an important target for treatment.
Results could impact the clinical care of patients with AD, supporting their treatment plan, overall quality of care.